San Francisco -- Invuity, a San Francisco-based developer of surgical visualization and illumination technology, said on Thursday it has raised $25 million in its fourth round of funding, which it plans to use to expand the development, manufacturing and commercialization of its medical devices. Valence Advantage led the round, which also included participation by Kleiner Perkins Caufield & Byers, InterWest Partners and Wexford Capital. The company's Eigr technology utilizes unique optical structures to control light output to a targeted operative space, virtually eliminating shadows, back reflection, glare and thermal effects. Philip Sawyer, the CEO of Invuity, said the technology "allows surgeons to clearly visualize anatomy during minimally invasive procedures, where typically sight is extremely limited."
http://www.invuity.com
http://www.invuity.com/invuity-raises-25-million-in-series-d-funding/